EXALGO |
021217 |
001 |
NDA |
HYDROMORPHONE HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2010/03/01
|
2010/03/01
|
SPECGX LLC |
Discontinued |
EXALGO |
021217 |
002 |
NDA |
HYDROMORPHONE HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2010/03/01
|
2010/03/01
|
SPECGX LLC |
Discontinued |
EXALGO |
021217 |
003 |
NDA |
HYDROMORPHONE HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2010/03/01
|
2010/03/01
|
SPECGX LLC |
Discontinued |
EXALGO |
021217 |
004 |
NDA |
HYDROMORPHONE HYDROCHLORIDE |
TABLET, EXTENDED RELEASE;ORAL |
32MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
2010/03/01
|
2012/08/24
|
SPECGX LLC |
Discontinued |